Related Experiment Video
Updated: Mar 18, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
Targeting blood pressure in people with diabetes mellitus
Insights
Treating hypertension in diabetes is crucial for cardiovascular health. Current guidelines vary, with trials like ACCORD and SPRINT offering conflicting evidence on optimal blood pressure targets for individuals with diabetes.
Area of Science:
- Cardiology
- Endocrinology
- Clinical Trials
Background:
- Hypertension is a significant risk factor for cardiovascular morbidity and mortality.
- The combination of hypertension and diabetes mellitus substantially elevates cardiovascular risk.
- Optimal blood pressure targets for patients with diabetes remain debated, leading to varied clinical practice guidelines.
Purpose of the Study:
- To review the current evidence and guidelines regarding blood pressure targets in patients with diabetes mellitus.
- To analyze the implications of trials like ACCORD and SPRINT on hypertension management in diabetic populations.
- To identify the need for further research on optimal blood pressure control in this high-risk group.
Main Methods:
- Review of existing clinical practice guidelines and landmark trials (ACCORD, SPRINT).
- Analysis of meta-analyses examining blood pressure targets in patients with diabetes.
- Discussion of the methodological limitations of current research.
Main Results:
- The ACCORD trial found no benefit in lowering systolic blood pressure (SBP) to <120 mmHg versus <140 mmHg in diabetics.
- The SPRINT trial showed benefits of SBP <120 mmHg, but excluded patients with diabetes.
- Meta-analyses suggest targeting SBP 130-140 mmHg for diabetics with baseline SBP >140 mmHg, noting potential risks of lower targets.
Conclusions:
- There is a lack of consensus on the optimal blood pressure target for individuals with diabetes.
- Lowering blood pressure targets may reduce stroke risk but could increase other cardiovascular risks.
- A large randomized controlled trial is needed to determine the ideal blood pressure targets in people with diabetes mellitus.
Abstract:
Hypertension is a strong risk factor for cardiovascular (CV)-related morbidity and mortality, and its treatment has been shown to be beneficial. Hypertension is common in people with diabetes mellitus, and the combination of these conditions markedly increases CV risk in comparison with individuals with neither condition. Although there is increasing clarity as to blood pressure (BP) targets in numerous conditions, the target in people with diabetes remains unclear, and, as a result, many clinical practice guidelines differ on the optimal BP goal. The ACCORD (Action to Control Cardiovascular Risk in Diabetes) trial did not demonstrate benefit when systolic BP (SBP) was lowered to less than 120 mmHg compared with a target of less than 140 mmHg. This was in contrast to the recent SPRINT trial (Systolic Blood Pressure Intervention Trial), which demonstrated the superiority of a target SBP of less than 120 mmHg in reducing CV events. However, people with diabetes mellitus were excluded. Recent meta-analyses have suggested that lowering BP in patients with diabetes mellitus should be reserved for a baseline SBP greater than 140 mmHg, targeting an SBP of between 130 and 140 mmHg. Lower targets may reduce the risk of stroke but may also be harmful with respect to other important CV outcomes. The methodological limitations of these meta-analyses highlight the need for a large randomized controlled trial comparing lower and standard BP targets in people with diabetes mellitus.
More Related Videos
10:07Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature
Published on: December 26, 2017
10:39Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo
Published on: March 8, 2018
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypertension V: Nursing Management
Antihypertensive Drugs: Action of Diuretics
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension and Regulation of Blood Pressure
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...